MICROMEDEX(R) Healthcare Series

SEROTONIN SYNDROME

REFERENCES
- GENERAL BIBLIOGRAPHY
  - 22. Dike GL: Triphasic waves in serotonin syndrome. J Neurol, Neurosurg, & Psychiatr 1997; 62(2):200.
  - 23. Dursun SM, Burke JG, Nielsen F et al: SSRI-related toxic serotonin syndrome: improvement of discontinuation of treatment and propranolol. Eur Psychiatr 1997; 12:321-323.
  - 24. FDA: Poison treatment drug product for over-the-counter human use; tentative final monograph. Fed Register 1985; 50:2244-2262.
  - 25. Fischer P: Serotonin syndrome in the elderly after antidepressive monotherapy (letter). J Clin Psychopharmacol 1995; 15:440-442.
  - 26. Francois B, Marquet P, Desachy A et al: Serotonin syndrome due to an overdose of moclobemide and clomipramine. Intens Care Med 1997; 23:122-124.
  - 27. Garofalo G, Ragusa RM, Barletta G et al: Schizophrenia and chromosomal fragile sites (letter). Am J Psychiatr 1992; 149:111-1117.
  - 28. George TP & Godleski LS: Possible serotonin syndrome with trazodone addition to fluoxetine (letter). Biol Psychiatr 1996; 39:384-385.
  - 29. Gill M, LoVecchio F & Selden B: Serotonin syndrome in a child after a single dose of fluvoxamine. Ann Emerg Med 1999; 33:457-459.
  - 30. Gillman PK: Ecstasy, serotonin syndrome and the treatment of hyperpyrexia (letter). MJA 1997; 167:109-111.
  - 31. Gillman PK: Possible serotonin syndrome with moclobemide and pethidine (letter). Med J Aust 1995; 162:554.
  - 32. Gillman PK: Serotonin syndrome - clomipramine too soon after moclobemide? Int Clin Psychopharmacol 1997; 12:339-342.
  - 33. Gillman PK: Successful treatment of serotonin syndrome with chlorpromazine (letter). MJA 1996; 165:345.
  - 34. Gillman PK: The serotonin syndrome and its treatment. J Psychopharmacol 1999; 13:100-109.
  - 35. Gitlin MJ: Venlafaxine, monoamine oxidase inhibitors, and the serotonin syndrome (letter). J Clin Psychopharmacol 1997; 17:66-67.
  - 36. Goldberg RJ & Huk M: Serotonin syndrome from trazodone and buspirone (letter). Psychosomatics 1992; 33:235-236.
  - 37. Graham PM: Successful treatment of the toxic serotonin syndrome with chloropromazine. MJA 1997; 166:166-167.
  - 38. Graudins A, Stearman A & Chan B: Serotonin syndrome successfully treated with cyproheptadine (abstract). J Tox Clin Tox 1997; 35:539-540.
  - 39. Guze BH & Baxter LR Jr: The serotonin syndrome: case responsive to propranolol (letter). J Clin Psychopharmacol 1986; 6:119-120.
  - 40. Harvey AT & Burke M: Comment on: the serotonin syndrome associated with paroxetine, an over-the-counter cold remedy, and vascular disease (letter). Am J Emerg Med 1995; 13:605-606.
  - 41. Heisler MA: Serotonin syndrome induced by administration of venlafaxine and phenelzine. Ann Pharmacother 1996; 30:84.
  - 42. Hilton SE, Maradit H & Moller HJ: Serotonin syndrome and drug combinations: focus on MAOI and RIMA. Eur Arch Psychiatr Clin Neurosci 1997; 247:113-119.
  - 43. Hodgman MJ, Martin TG & Krenzelok EP: Serotonin syndrome due to venlafaxine and maintenance tranylcypromine therapy. Hum Exp Toxicol 1997; 16:14-17.
  - 44. Hoes MJAJM: Mirtazapine as treatment for serotonin syndrome. Pharmacopsychiatry 1996; 29:81.
  - 45. Hubmayr RD & Irwin RS: Mechanical ventilation: Initiation, in: Irwin RS, Cerra FB, Rippe JM (eds), Irwin & Rippe's Intensive Care Medicine, Vol 1, 4th ed. Lippincott-Raven Publishers, Philadelphia, PA, 1999.
  - 46. Insel TR, Roy BF, Cohen RM et al: Possible development of the serotonin syndrome in man. Am J Psychiatr 1982; 139:954-955.
  - 47. Ivanusa Z, Hecimovic H & Demarin V: Serotonin syndrome. Neuropsychiatr, Neuropsychol & Behavior Neurol 1997; 10:209-212.
  - 48. Jahr JS, Pisto JD, Gitlin MC et al: The serotonin syndrome in a patient receiving sertraline after an ankle block. Anesth Analg 1994; 79:189-191.
  - 49. John L, Perreault MM, Tao T et al: Serotonin syndrome associated with nefazodone and paroxetine. Ann Emerg Med 1997; 29:287-289.
  - 50. Keltner N: Serotonin syndrome: a case of fatal SSRI/MAOI interaction. Perspective Psychiatr Care 1994; 30:26-31.
  - 51. Kline SS, Mauro LS, Scala-Barnett DM et al: Serotonin syndrome versus neuroleptic malignant syndrome as a cause of death. Clin Pharmac 1989; 8:510-514.
  - 52. Kolecki P: Venlafaxine induced serotonin syndrome occurring after abstinence from phenelzine for more than two weeks (letter). Clin Toxicol 1997; 35:211-212.
  - 53. Kollef MH & Schuster DP: The acute respiratory distress syndrome. N Engl J Med 1995; 332:27-37.
  - 54. Kudo K, Sasaki I, Tsuchiyama K et al: Serotonin syndrome during clomipramine monotherapy: comparison of two diagnostic criteria. Psychiatr & Clin Neurosc 1997; 51:43-46.
  - 55. Kuisma MJ: Fatal serotonin syndrome with trismus (letter). Ann Emerg Med 1995; 26:108.
  - 56. Lahat E, Goldman M, Barr J et al: Comparison of intranasal midazolam with intravenous diazepam for treating febrile seizures in children: prospective randomized study. BMJ 2000; 321:83-86.
  - 57. Lai NY, Silbert PL, Erber WN et al: "Nanging": another cause of nitrous oxide neurotoxicity. MJA 1997; 166:166-167.
  - 58. Lejoyeux M, Fineyre F & Ades J: The serotonin syndrome (letter). Am J Psychiatr 1992; 149:1410-1411.
  - 59. Levy F, Einfeld S & Looi J: Combined pharmacotherapy or polypharmacy? J Paediatr Child Health 1996; 32:265-266.
  - 60. Martin TG: Serotonin syndrome. Ann Emerg Med 1996; 28:520-526.
  - 61. Mason BJ & Blackburn KH: Possible serotonin syndrome associated with tramadol and sertraline coadministration. Ann Pharmacother 1997; 31:175-177.
  - 62. Matthew NT, Tietjen GE & Lucker C: Serotonin syndrome complicating migraine pharmacotherapy. Cephalalgia 1996; 16:323-327.
  - 63. Mills KC: Serotonin syndrome. Am Fam Physician 1995; 52:1475-1482.
  - 64. Mills KC: Serotonin syndrome: a clinical update. Med Toxicol 1997; 13:763-783.
  - 65. Miyaoka H & Kamijima K: Encephalopathy during amitriptyline therapy: are neuroleptic malignant syndrome and serotonin syndrome spectrum disorders? Intern Clin Psychopharmacol 1995; 10:265-267.
  - 66. Nijhawan PK, Katz G & Winter S: Psychiatric illness and the serotonin syndrome: an emerging adverse drug effect leading to intensive care unit admission. Crit Care Med 1996; 24:1086-1089.
  - 67. Nisijima K, Shimizu M, Abe T et al: A case of serotonin syndrome induced by concomitant treatment with low-dose trazodone and amitriptyline and lithium. Intern Clin Psychopharmacol 1996; 11:289-290.
  - 68. Pao M & Tipnis T: Serotonin syndrome after sertraline overdose in a 5-year-old girl. Arch Pediatr Adolesc Med 1997; 151:1064-1067.
  - 69. Power BM, Pinder M, Hackett LP et al: Fatal serotonin syndrome following a combined overdose of moclobemide, clomipramine and fluoxetine. Anaesth IIntense Care 1995; 23:499-502.
  - 70. Price LH, Charney DS & Heninger GR: Serotonin syndrome. Am J Psychiatr 1992; 149:116-117.
  - 71. Price WA, Zimmer B & Kucas P: Serotonin syndrome: a case report. J Clin Pharmacol 1986; 26:77-78.
  - 72. Product Information Ativan(R), 1999, Wyeth-Ayerst Co, Philadelphia, PA
  - 73. Rao R: Serotonin syndrome associated with trazodone (letter). Intern J Geriatr Psychiatr 1997; 12:129-132.
  - 74. Reeves RR & Bullen JA: Serotonin syndrome produced by paroxetine and low-dose trazodone (letter). Psychosomatics 1995; 36:159-160.
  - 75. Reynolds RD: Serotonin syndrome cause and treatment (letter). JABFP 1996; 9:73-74.
  - 76. Richard IH, Kurlan R, Tanner C et al: Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson's disease. Am Acad Neurol 1997; 48:1070-1077.
  - 77. Rosebush PI & Margetts P: Serotonin syndrome as a result of clomipramine monotherapy. J Clin Psychopharmacol 1999; 19:285-287.
  - 78. Roxanas MG & Machado JFD: Serotonin syndrome in combined moclobemide and venlafaxine ingestion (letter). MJA 1998; 168:523-524.
  - 79. Ruiz F: Fluoxetine and the serotonin syndrome. Ann Emerg Med 1994; 24:983-985.
  - 80. Sandyk R: L-dopa induced "serotonin syndrome" in a Parkinsonian patient on Bromocriptine (letter). J Clin Psychopharmacol 1986; 6:194-195.
  - 81. Scott R, Besag FMC, Neville BGR: Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomized trial. Lancet 1999; 353:623-626.
  - 82. Skop BP, Finkelstein JA, Mareth TR et al: The serotonin syndrome associated with paroxetine, an over-the-counter cold remedy, and vascular disease. Am J Emerg Med 1994; 12:642-644.
  - 83. Sporer KA: The serotonin syndrome: implicated drugs, pathophysiology and management. Drug Safety 1995; 13:94-104.
  - 84. Sternbach H: The serotonin syndrome. Am J Psychiatr 1991; 148:705-713.
  - 85. Sternbach H: The serotonin syndrome. Am J Psychiatr 1992; 149:1410-1411.
  - 86. USP DI Volume I Drug information for the health care professional. 20th edition, 2000; Micromedex Inc, World Color Book Services, Taunton, MA.
  - 87. Vale JA: Position Statement: gastric lavage. American Academy of Clinical Toxicology/European Association of Poisons Centres and Clinical Toxicologists. Clin Toxicol 1997; 35:711-719.
  - 88. Weiner LA, Smythe M & Cisek J: Serotonin syndrome secondary to phenelzine- venlafaxine interaction. Pharmacotherapy 1998; 18:399-403.
  - 89. Weiss DM: Serotonin syndrome in Parkinson Disease. JABFP 1995; 8:400-402.
  - 90. Williams A: The serotonin syndrome. Emerg Med 1997; 9:199-206.
13.0 AUTHOR INFORMATION
- 13.1 CONTRIBUTOR(S) TO THIS DOCUMENT
  - A. Original publication: 11/97
  - B. Most recent revision: 06/99
  - C. List of contributors:
```
      1.   Katherine M. Hurlbut, MD 
      2.   POISINDEX(R) Editorial Staff 
```
  - D. Specialty Board: PSYCHOACTIVE AND ABUSE
    - Refer to the POISINDEX EDITORIAL BOARD section for more information. (MG2114)

End of Document
Back to "Serotonin Syndrome"
Home Antidepressants Facts